Skip to main content

Aurora Spine Corporation(ASG-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.275
Day High0.275
Open:0.275
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

Top Stories: Aurora Spine Corporation

Select a category then submit the form to load news
Aurora Spine Corporation to Participate in the 38th Annual ROTH Conference
AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER
Aurora Spine Announces Issuance of Two U.S. Patents
Aurora Spine Corporation Announces Record Third Quarter Financial Results
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
Aurora Spine Launches New Biologics Portfolio
Aurora Spine Announces Proposed Warrant Extension
Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device
Aurora Spine Corporation Announces Record Second Quarter Financial Results
Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference
Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results
Aurora Spine Corporation Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX™ Sacroiliac Fusion System
Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System
Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion 
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results
Aurora Spine Corporation Announces Third Quarter 2024 Financial Results
Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut
Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets

Profile

Aurora Spine Corp is engaged in the development, manufacture, and selling of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.